Kyorin Holdings Inc
TSE:4569
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 467
1 853
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Kyorin Holdings Inc
Kyorin Holdings Inc
Net Change in Cash
Kyorin Holdings Inc
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kyorin Holdings Inc
TSE:4569
|
Net Change in Cash
-¥11.6B
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-9%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Net Change in Cash
¥541B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Net Change in Cash
¥116.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Net Change in Cash
-¥3.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Net Change in Cash
¥236.5B
|
CAGR 3-Years
189%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Net Change in Cash
-¥258.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
Kyorin Holdings Inc
Glance View
KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.
See Also
What is Kyorin Holdings Inc's Net Change in Cash?
Net Change in Cash
-11.6B
JPY
Based on the financial report for Sep 30, 2024, Kyorin Holdings Inc's Net Change in Cash amounts to -11.6B JPY.
What is Kyorin Holdings Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-9%
Over the last year, the Net Change in Cash growth was -716%. The average annual Net Change in Cash growth rates for Kyorin Holdings Inc have been -37% over the past three years , -32% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
